About Fantasia Trade
Fantasia Trade is a Healthcare company based in Thane (India). It serves as a CDMO specializing in the manufacturing of active pharmaceutical ingredients. It operates on a B2B model. Its Indian entity Minerva Pharmatrade Private Limited reported revenue of ₹9.33 Cr. Its focus areas include Pharmaceuticals, Manufacturing and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Fantasia Trade serves as a cdmo specializing in the manufacturing of active pharmaceutical ingredients through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Thane, India
- SectorsHealthcare
- Website ww25.fantasiatrade.com
- Legal Name Fantasia Trade Private Limited
- Date of Incorporation 12 Jul, 2013
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹9.33 Cr
FY 2025 · -26% YoY
- Net Loss-₹1.30 Cr
FY 2025 · -14% margin
- EBITDA-₹50.3 Lakh
FY 2025 · -5% margin
Associated legal entities of Fantasia Trade
Fantasia Trade operates through Minerva Pharmatrade Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Minerva Pharmatrade Private Limited CIN U74999MH2013PTC245557 | Active | 12 Jul 2013 | Thane, Maharashtra | ₹9.3 Cr | 3 | View details |
Board of directors of Minerva Pharmatrade Private Limited (Fantasia Trade)
Minerva Pharmatrade Private Limited is the primary company behind Fantasia Trade. The board of Minerva Pharmatrade Private Limited currently have 3 directors; the longest-serving is Vignesh, appointed in 2021. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vignesh DIN 09029584 | Director | 01 Mar 2021 | 5 yrs 8 mo | Minerva Pharmatrade Private Limited |
| Shahrukh Arif Sayyed DIN 10859810 | Additional Director | 04 Dec 2024 | 1 yr 10 mo | Minerva Pharmatrade Private Limited |
| Ibrahim Nasir Shaikh DIN 10860614 | Additional Director | 04 Dec 2024 | 1 yr 10 mo | Minerva Pharmatrade Private Limited |
Financials of Fantasia Trade
Figures of Minerva Pharmatrade Private Limited, the primary company behind Fantasia Trade, for FY 2025. Revenue was ₹9.33 Cr (-26% year on year). Net loss was -₹1.30 Cr (-14% margin). EBITDA was -₹50.3 Lakh (-5% margin). Revenue has grown at a compounded annual rate of -71% over three years.
- ₹9.33 CrRevenue · FY 2025 · -26% YoY
- -₹1.30 CrNet loss · -14% margin
- -₹50.3 LakhEBITDA · -5% margin
- ₹1 LakhPaid-up capital
- -71%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Minerva Pharmatrade Private Limited are on its company page.
Detailed financial statements for Fantasia Trade
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Fantasia Trade
Fantasia Trade has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Fantasia Trade
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fantasia Trade
Fantasia Trade is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
The primary company behind Fantasia Trade, Minerva Pharmatrade Private Limited, reported revenue of ₹9.33 Cr for FY 2025, down 26% year on year.
Fantasia Trade serves as a cdmo specializing in the manufacturing of active pharmaceutical ingredients through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and api production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Fantasia Trade's top competitors include Laurus Labs, Symbiotec and SeQuent.
Fantasia Trade operates through Minerva Pharmatrade Private Limited.
The legal entities of Fantasia Trade currently have 3 directors, including Vignesh, Shahrukh Arif Sayyed, Ibrahim Nasir Shaikh.